FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 2173723 · Received July 23, 2011

Report

Report Number
2124215-2011-10790
Event Type
Injury
Date Received
July 23, 2011
Date of Event
June 17, 2011
Report Date
July 8, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
PMA / PMN Number
P910073
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

AT THIS TIME THE DEVICE REMAINS IMPLANTED. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS PRODUCT IS A PART OF A PLANNED SYSTEM EXPLANT DUE TO A PATIENT INFECTION. THERE WAS NO REPORT OF ADVERSE PATIENT EFFECTS.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED INDICATING THIS PRODUCT WAS EXPLANTED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0184

Patients

Seq Age Sex Outcome Treatment
1 47 YR Required Intervention 4086| T127| 0184